One would think GILD would have priced up a lot today, perhaps a gap up after that amazing and coveted first to CV19 market approval.
What happened?
They're oh so just above their 52 week low and slightly.
Gained $0.12 at close today.
Why?
It's a sub-par product with sub-par fundamentals. The medical professionals know this.
As NP mentioned during that PA video, all we need to do, is beat '1'.
Bar is set so low, CYDY can literally step over it as we know the science and we've seen the data from previous trials/EIND.
This week and days like today where we break previous held support and the drops are rough but the science and conviction of shareholders that have a longer term horizon will be rewarded, and heavily at that.
Next week will be fun. We are very close. We will see downside capitulation. Convergence is nigh.
GLTU/A.
DON'T BLINK